SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-051653
Filing Date
2020-11-06
Accepted
2020-11-06 06:59:25
Documents
88
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q epzm-10q_20200930.htm   iXBRL 10-Q 3411046
2 EX-10.1 epzm-ex101_182.htm EX-10.1 30918
3 EX-31.1 epzm-ex311_8.htm EX-31.1 8520
4 EX-31.2 epzm-ex312_6.htm EX-31.2 8505
5 EX-32.1 epzm-ex321_9.htm EX-32.1 6310
  Complete submission text file 0001564590-20-051653.txt   11525237

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA epzm-20200930.xsd EX-101.SCH 77593
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE epzm-20200930_cal.xml EX-101.CAL 61802
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE epzm-20200930_def.xml EX-101.DEF 274100
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE epzm-20200930_lab.xml EX-101.LAB 567526
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epzm-20200930_pre.xml EX-101.PRE 457048
11 EXTRACTED XBRL INSTANCE DOCUMENT epzm-10q_20200930_htm.xml XML 2118264
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35945 | Film No.: 201292357
SIC: 2834 Pharmaceutical Preparations